Physician

Arveen Bhasin, MD

According to 2025 Medicare claims, Arveen Bhasin, MD (NPI: 1376641183) practices allergy/immunology in the Jacksonville, FL market, with the plurality of this provider's patient population coming from Duval, FL. This provider's primary affiliated billing organization is MAYO CLINIC JACKSONVILLE (NPI: 1790772317; TIN: 593337028) and primary practice location at 32224-1865.

Bhasin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 204 traditional Medicare patients, billed 14,453 HCPCS/CPT codes, and received $331,565 in Medicare payments. The top billing code was 90677 (Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use). Part D data shows 280 prescription claims across 60 beneficiaries totaling $774,482 in drug costs, led by Takhzyro (Lanadelumab-Flyo). DME data shows 26 claims. Open Payments data shows 4 records totaling $2,476. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $105,849 to $331,565. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $68,912 to $774,482. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	731	4,772	$105,849
2016	1,262	6,659	$174,927
2017	1,018	4,251	$125,235
2018	599	2,614	$75,978
2019	782	3,858	$108,221
2020	505	3,917	$97,794
2021	350	4,024	$118,813
2022	366	5,310	$132,133
2023	363	13,311	$280,207
2024	204	14,453	$331,565

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	58	240	$68,912
2016	52	221	$149,241
2017	63	260	$154,340
2018	65	317	$190,947
2019	98	402	$240,096
2020	97	368	$906,815
2021	55	312	$825,330
2022	82	368	$869,634
2023	78	341	$1,009,175
2024	60	280	$774,482

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	35	$72,114
2024	N/R	26	$85,597

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90677	Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use	27	27	$289
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	39	39	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	29	34	$66
G0009	Administration of pneumococcal vaccine	31	31	$32
96372	Injection of drug or substance under skin or into muscle	27	214	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Takhzyro	Lanadelumab-Flyo	11	308	$282,844
Xolair	Omalizumab	31	868	$146,852
Nucala	Mepolizumab	29	896	$121,779
Icatibant	Icatibant Acetate	18	192	$48,749
Pulmicort Flexhaler	Budesonide	19	570	$5,154

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	13	$85,124
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$473

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$207	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$2,270	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arveen Bhasin, MD?

Tedicare shows public-source Medicare data for Arveen Bhasin, MD (NPI 1376641183), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arveen Bhasin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arveen Bhasin, MD?

Arveen Bhasin, MD is linked to MAYO CLINIC JACKSONVILLE (billing NPI 1790772317) in the available physician profile data.

Does Arveen Bhasin, MD have Open Payments data?

Arveen Bhasin, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.